España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
XOMA Royalty
XOMA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$23.52
-1.02
-4.16%
At close: -
$23.52
0.00
0.00%
After Hours: Feb 21, 4:02 PM EDT
Get Report
Comment
XOMA Royalty (XOMA) Forecast
News
Earnings
XOMA Royalty (XOMA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for XOMA Royalty (NASDAQ:XOMA) Stock
XOMA Royalty Stock (NASDAQ: XOMA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, February 03, 2025
Forecasting The Future: 5 Analyst Projections For XOMA Royalty
Benzinga Insights
HC Wainwright & Co. Maintains Buy on XOMA Roy...
Benzinga Newsdesk
Tuesday, January 07, 2025
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk
Friday, December 13, 2024
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk
Tuesday, December 03, 2024
A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on XOMA Roy...
Benzinga Newsdesk
Monday, December 02, 2024
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk
XOMA Royalty shares are trading higher after ...
Benzinga Newsdesk
XOMA Royalty Said It Owns An Economic Interes...
Benzinga Newsdesk
Thursday, November 07, 2024
XOMA Q3 2024 GAAP EPS $(1.59) Misses $(0.44) ...
Benzinga Newsdesk
Wednesday, October 23, 2024
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk
Tuesday, October 22, 2024
Twist Bioscience Enters Royalty Purchase Agre...
Benzinga Newsdesk
Monday, September 23, 2024
XOMA Royalty Says Zevra Therapeutics Received...
Benzinga Newsdesk
XOMA Announces $0.53906 for Series A, $0.5234...
Benzinga Newsdesk
Friday, September 20, 2024
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Maintains Buy on XOMA Roy...
Benzinga Newsdesk
Tuesday, August 13, 2024
XOMA Q2 2024 GAAP EPS $0.84 Beats $(0.27) Est...
Benzinga Newsdesk
Tuesday, July 09, 2024
FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
Vandana Singh
Demystifying XOMA: Insights From 5 Analyst Reviews
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Wednesday, June 12, 2024
XOMA Disclosed It Had Received An $8.1M Miles...
Benzinga Newsdesk
Friday, May 31, 2024
Peeling Back The Layers: Exploring XOMA Through Analyst Insights
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Thursday, May 09, 2024
XOMA Q1 2024 GAAP EPS $(0.86) Misses $(0.81) ...
Benzinga Newsdesk
Friday, May 03, 2024
Lexicon Pharmaceuticals Reports Q1 Loss, Misses Revenue Estimates
Zacks
Wednesday, May 01, 2024
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Tuesday, April 30, 2024
Xoma Has Acquired An Economic Interest In Thr...
Benzinga Newsdesk
Monday, April 29, 2024
Cracking The Code: Understanding Analyst Reviews For XOMA
Benzinga Insights
Leerink Partners Initiates Coverage On XOMA w...
Benzinga Newsdesk
Thursday, April 25, 2024
Xoma Earns $9M As FDA Grants Accelerated Appr...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Tuesday, March 19, 2024
XOMA Corp Entered Into A Merger Agreement To ...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on XOMA, Ma...
Benzinga Newsdesk
Friday, March 08, 2024
Recap: XOMA Q4 Earnings
Benzinga Insights
XOMA FY GAAP EPS $(4.04) May Not Be Comparabl...
Benzinga Newsdesk
Friday, February 16, 2024
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
Vandana Singh
XOMA Enters Agreement To Acquire Kinnate Biop...
Benzinga Newsdesk
Trading Halt: Halted at 7:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Thursday, January 18, 2024
Talphera Announces $26M Capital Commitment Th...
Benzinga Newsdesk
XOMA Expands Its Commercial Royalty And Miles...
Benzinga Newsdesk
Thursday, January 11, 2024
XOMA To Make $1M Milestone Payment To LadRx, ...
Benzinga Newsdesk
Monday, January 08, 2024
XOMA Names Owen Hughes As CEO And Jack Wyszom...
Benzinga Newsdesk
Tuesday, January 02, 2024
XOMA Corporation Has Authorized XOMA's First ...
Benzinga Newsdesk
Friday, December 22, 2023
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Tuesday, November 07, 2023
XOMA Q3 EPS $(0.60) Misses $(0.48) Estimate, ...
Benzinga Newsdesk
Tuesday, October 31, 2023
XOMA Earns $5M Milestone Upon FDA Acceptance ...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Wednesday, September 13, 2023
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Monday, September 11, 2023
On Sept 11, 2023, XOMA Corporation Received $...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
